Search Results - "Schramm, T. K."

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study by Andersson, C, Olesen, J. B, Hansen, P. R, Weeke, P, Norgaard, M. L, Jørgensen, C. H, Lange, T, Abildstrøm, S. Z, Schramm, T. K, Vaag, A, Køber, L, Torp-Pedersen, C, Gislason, G. H

“…Aims/hypothesis The safety of metformin in heart failure has been questioned because of a perceived risk of life-threatening lactic acidosis, though recent…”
Get full text

Risk of Myocardial Infarction and Death Associated With the Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Among Healthy Individuals: A Nationwide Cohort Study by Fosbøl, EL, Gislason, GH, Jacobsen, S, Folke, F, Hansen, ML, Schramm, TK, Sørensen, R, Rasmussen, JN, Andersen, SS, Abildstrom, SZ, Trærup, J, Poulsen, HE, Rasmussen, S, Køber, L, Torp‐Pedersen, C

“…Use of some nonsteroidal anti‐inflammatory drugs (NSAIDs) is associated with increased cardiovascular risk in several patient groups, but whether this excess…”
Get full text

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study by Norgaard, M. L, Andersen, S. S, Schramm, T. K, Folke, F, Jørgensen, C. H, Hansen, M. L, Andersson, C, Bretler, D. M, Vaag, A, Køber, L, Torp-Pedersen, C, Gislason, G. H

“…Aims/hypothesis We assessed secular trends of cardiovascular outcomes following first diagnosis of myocardial infarction (MI) or diabetes in an unselected…”
Get full text

Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction — A nationwide study by Jørgensen, C.H, Gislason, G.H, Bretler, D, Sørensen, R, Norgaard, M.L, Hansen, M.L, Schramm, T.K, Abildstrom, S.Z, Torp-Pedersen, C, Hansen, P.R

“…Abstract Background Sulfonylureas have been linked to an increased cardiovascular risk by inhibition of myocardial preconditioning. Whether individual…”
Get full text

Clinical consequences of hospital variation in use of oral anticoagulant therapy after first‐time admission for atrial fibrillation by Hansen, M. L., Gadsbøll, N., Rasmussen, S., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., Sørensen, R., Fosbøl, E. L., Abildstrøm, S. Z., Madsen, M., Poulsen, H. E., Køber, L., Torp‐Pedersen, C.

“… Objective.  To analyse how hospital factors influence the use of oral anticoagulants (OAC) in atrial fibrillation (AF) patients and address the clinical…”
Get full text

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus - a retrospective nationwide study by Mogensen, U. M., Andersson, C., Fosbøl, E. L., Schramm, T. K., Vaag, A., Scheller, N. M., Torp-Pedersen, C., Gislason, G., Køber, L.

“…Aim Dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 (GLP‐1) agonists are widely used in combinations with metformin in the treatment of…”
Get full text

Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006 by Dominguez, H, Schramm, T K, Norgaard, M L, Abildstrøm, S Z, Kober, L, Jørgensen, C, Guterbaum, T J, Poulsen, H E, Torp-Pedersen, C, Gislason, G H

“…Since 2001 guidelines recommend statin treatment in most patients with diabetes. We investigated secular changes in initiation and persistence to statin…”
Get full text

Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes by Prutsky, Gabriela, Domecq, Juan Pablo, Tsapas, Apostolos

“…Prutsky et al comment on a study by Schramm et al determining the safety of insulin secretagogues compared with metformin for mortality and cardiovascular risk…”
Get full text

Differences in mortality and cardiovascular risk associated with insulin in combination with individual insulin secretagogues or metformin - a nationwide study by Mogensen, U. M., Andersson, C., Fosbol, E. L., Schramm, T. K., Vaag, A., Scheller, N. M., Pedersen, C. T., Gislason, G., Kober, L.

Get full text

DPP-4 inhibitors and GLP-1 agonists in type 2 diabetes - early assessment of cardiovascular safety in a nationwide setting by Mogensen, U. M., Andersson, C., Fosbol, E. L., Schramm, T. K., Vaag, A., Scheller, N. M., Pedersen, C. T., Gislason, G., Kober, L.

Get full text

Use of statins and beta-blockers after acute myocardial infarction according to income and education by Rasmussen, Jeppe N, Gislason, Gunnar H, Rasmussen, Søren, Abildstrom, Steen Z, Schramm, Tina K, Køber, Lars, Diderichsen, Finn, Osler, Merete, Torp-Pedersen, Christian, Madsen, Mette

“…Objective:To study the initiation of and long-term refill persistency with statins and beta-blockers after acute myocardial infarction (AMI) according to…”
Get full text

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study by Schramm, T. K., Gislason, G. H., Vaag, A., Rasmussen, J. N., Folke, F., Hansen, M. L., Fosbol, E. L., Kober, L., Norgaard, M. L., Madsen, M., Hansen, P. R., Torp-Pedersen, C.

Get full text

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction by GISLASON, Gunnar H, JACOBSEN, Søren, TORP-PEDERSEN, Christian, RASMUSSEN, Jeppe N, RASMUSSEN, Søren, BUCH, Pernille, FRIBERG, Jens, SCHRAMM, Tina Ken, ABILDSTROM, Steen Z, KØBER, Lars, MADSEN, Mette

“…The selective cyclooxygenase-2 (COX-2) inhibitors and other nonselective nonsteroidal antiinflammatory drugs (NSAIDs) have been associated with increased…”
Get full text

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study by Andersen, Søren Skøtt, Hansen, Morten Lock, Gislason, Gunnar H., Schramm, Tina Ken, Folke, Fredrik, Fosbøl, Emil, Abildstrøm, Steen Z., Madsen, Mette, Køber, Lars, Torp-Pedersen, Christian

“…Aims To examine the risk of death associated with antiarrhythmic drug (AAD) therapy in a nationwide unselected cohort of patients with atrial fibrillation…”
Get full text

Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers by Hansen, Morten Lock, Gadsbøll, Niels, Gislason, Gunnar H., Abildstrom, Steen Z., Schramm, Tina K., Folke, Fredrik, Friberg, Jens, Sørensen, Rikke, Rasmussen, Søren, Poulsen, Henrik E., Køber, Lars, Madsen, Mette, Torp-Pedersen, Christian

“…Aims To study evolvement in pharmacotherapy of atrial fibrillation from 1995 to 2004. Methods and results All Danish patients were discharged following…”
Get full text

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure by Gislason, Gunnar H, Rasmussen, Jeppe N, Abildstrom, Steen Z, Schramm, Tina K, Hansen, Morten L, Fosbøl, Emil L, Sørensen, Rikke, Folke, Fredrik, Buch, Pernille, Gadsbøll, Niels, Rasmussen, Søren, Poulsen, Henrik E, Køber, Lars, Madsen, Mette, Torp-Pedersen, Christian

“…Accumulating evidence indicates increased cardiovascular risk associated with nonsteroidal anti-inflammatory drug (NSAID) use, in particular in patients with…”
Get more information